Pituitary adenylyl cyclase‐activating polypeptide controls the proliferation of retinal progenitor cells through downregulation of cyclin D1
- 2 August 2010
- journal article
- Published by Wiley in European Journal of Neuroscience
- Vol. 32 (3) , 311-321
Abstract
During retinal development, cell proliferation and exit from the cell cycle must be precisely regulated to ensure the generation of the appropriate numbers and proportions of the various retinal cell types. Previously, we showed that pituitary adenylyl cyclase‐activating polypeptide (PACAP) exerts a neuroprotective effect in the developing retina of rats, through the cAMP–cAMP‐dependent protein kinase (protein kinase A) (PKA) pathway. Here, we show that PACAP also regulates the proliferation of retinal progenitor cells. PACAP, PACAP‐specific receptor (PAC1), and the receptors activated by both PACAP and vasoactive intestinal peptide (VIP), VPAC1 and VPAC2, are expressed during embryonic and postnatal development of the rat retina. Treatment of retinal explants with PACAP38 reduced the incorporation of [3H]thymidine as well as the number of 5‐bromo‐2′‐deoxyuridine‐positive and cyclin D1‐positive cells. Pharmacological experiments indicated that PACAP triggers this antiproliferative effect through the activation of both PAC1 and VPACs, and the cAMP–PKA pathway. In addition, PACAP receptor activation decreased both cyclin D1 mRNA and protein content. Altogether, the data support the hypothesis that PACAP is a cell‐extrinsic regulator with multiple roles during retinal development, including the regulation of proliferation in a subpopulation of retinal progenitor cells.Keywords
This publication has 64 references indexed in Scilit:
- N-myc coordinates retinal growth with eye size during mouse developmentGenes & Development, 2008
- Exendin-4 induction of cyclin D1 expression in INS-1 β-cells: involvement of cAMP-responsive elementJournal of Endocrinology, 2006
- Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina developmentDevelopmental Brain Research, 2005
- Wagging the DogmaCell, 2004
- Apotransferrin induces cAMP/CREB pathway and cell cycle exit in immature oligodendroglial cellsJournal of Neuroscience Research, 2004
- Pituitary Adenylyl Cyclase-activating Polypeptide Prevents Induced Cell Death in Retinal Tissue through Activation of Cyclic AMP-dependent Protein KinaseJournal of Biological Chemistry, 2002
- Persistent expression of cyclin D1 disrupts normal photoreceptor differentiation and retina developmentOncogene, 2001
- Transcriptional regulation by the phosphorylation-dependent factor CREBNature Reviews Molecular Cell Biology, 2001
- Protein kinases selectively modulate apoptosis in the developing retina in vitroNeurochemistry International, 1997
- Induction of differentiation of rat retinal, germinal, neuroepithelial cells by dbcAMPJournal of Neurobiology, 1990